Danyi Granule Dossier

A formulation dossier focused on digestive inflammatory conditions, especially cholecystitis and pancreatitis, with emphasis on recovery-phase management.

Patent Overview

A formulation dossier focused on digestive inflammatory conditions, especially cholecystitis and pancreatitis, with emphasis on recovery-phase management.

Indication: Cholecystitis Direction, Pancreatitis Direction, Communication of Information on Inflammatory Diseases of the Digestive System

Principle and Advantage

Bile and Pancreas Granules are more suitable to be positioned within the portfolio context of 'Management of Acute and Chronic Inflammation and Recovery Phase in the Digestive System.' Its value lies in providing a standardized traditional Chinese medicine formulation that complements surgical, antibiotic, and supportive treatments.

Scientific Basis: Soothing the Liver and Regulating Qi, Clearing Heat and Detoxifying, Integrated Traditional Chinese and Western Medicine Approach to Digestive System Treatment

  • Features a clear narrative regarding its origin as an in-hospital formulation.
  • The clinical scenarios are specific, making it easy for partners to understand where it can be applied.
  • Can serve as a more clinically prescription-oriented entry within the digestive system asset portfolio.

Market Context

Market reference:Clinical setting: Common digestive inflammatory conditions; Product gap: Limited TCM product options

  • Inflammation and recovery phase management in the digestive system have clear clinical scenarios.
  • Granule dosage forms help transform hospital-based formulations into more standardized communication materials.
  • This asset helps organize years of clinical experience into a collaboratively applicable technical entry.

Antibiotic regimens

Anti-infective therapy · Common basic pathways in the treatment of cholecystitis and related infections.

The patent background lists antibiotics and surgery as current common Western medical treatments.

Surgical intervention

Procedure-based treatment · Core treatment pathways for some cases of cholecystitis and related acute attacks.

Used to describe the current treatment landscape in which this asset is positioned.

Supportive care

Recovery-phase management · Long-term recovery and relapse management following treatment for pancreatitis and cholecystitis.

This asset is more suitable for integration into the recovery phase and combined management contexts.

Related Books

Cooperation

Suitable for technical exchanges, exploration of in-hospital formulation conversion, and early-stage collaboration assessment in the field of inflammatory diseases of the digestive system.

Indication · March 18, 2026

合规提示

This page is for academic exchange and collaboration reference and does not constitute medical advice, product marketing, or efficacy claims.